BOSTON, July 31, 2023 /PRNewswire/ — On July 25, 2023, Fosun Health Capital established by Fosun Pharma (stock code:600196.SH), reached a strategic partnership with Medicilon (stock code: 688202.SH). Meanwhile StarMab Biology (Suzhou) (jointly invested by the innovation drug research fund of Fosun Group and Yaopharma) and Medicilon entered into a…Read More
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together
